INNOVENT - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88177424
Serial Number
88177424
Registration Number
6236173
Word Mark
INNOVENT
Status
700 - Registered
Status Date
2021-01-05
Filing Date
2018-11-01
Registration Number
6236173
Registration Date
2021-01-05
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261709, 270301, 280103 - Curved line(s), band(s) or bar(s). Geometric figures forming letters or numerals, including punctuation. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2020-10-20
Attorney Name
Anessa Owen Kramer
Law Office Assigned Location Code
S10
Employee Name
PATE, TARA J
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENGWUZHIYAO"
Description of Mark
The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT".
Goods and Services
Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes
Transliteration Statement
The non-Latin characters in the mark transliterate to "XIN DA SHENG WU ZHI YAO" and this means "integrity", "action", "bio-pharmaceuticals" in English.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-16
Primary Code
005
Current Trademark Owners
Party Name
Innovent Biologics (Suzhou) Co., Ltd.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Innovent Biologics (Suzhou) Co., Ltd.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Innovent Biologics (Suzhou) Co., Ltd.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Innovent Biologics (Suzhou) Co., Ltd.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Anessa Owen Kramer
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
China P.Rep.False
Trademark Events
Event DateEvent Description
2018-11-05NEW APPLICATION ENTERED IN TRAM
2018-11-16NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-11-17NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-02-07ASSIGNED TO EXAMINER
2019-03-11NON-FINAL ACTION WRITTEN
2019-03-11NON-FINAL ACTION E-MAILED
2019-03-11NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-08-23TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-08-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-08-24TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-26FINAL REFUSAL WRITTEN
2020-02-26FINAL REFUSAL E-MAILED
2020-02-26NOTIFICATION OF FINAL REFUSAL EMAILED
2020-03-12TEAS REQUEST FOR RECONSIDERATION RECEIVED
2020-03-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-03-13TEAS/EMAIL CORRESPONDENCE ENTERED
2020-03-19APPROVED FOR PUB - PRINCIPAL REGISTER
2020-04-01NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-04-21PUBLISHED FOR OPPOSITION
2020-04-21OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-06-16NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-07-24TEAS PETITION TO AMEND BASIS RECEIVED
2020-09-09ASSIGNED TO PETITION STAFF
2020-09-11PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
2020-09-11ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
2020-09-17NOTICE OF ALLOWANCE CANCELLED
2020-09-171(B) BASIS DELETED; NEW BASIS REQUESTED
2020-09-30NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-10-20PUBLISHED FOR OPPOSITION
2020-10-20OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-01-05REGISTERED-PRINCIPAL REGISTER